Graves' disease and hyperthyroidism trials in Chile
2 of 2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Where
- Santiago
- Age
- 18 years to 75 years
- People
- 210 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT07018323 · EU 2025-521920-31-00 - Phase 2Taking peopleA Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
- Where
- Concepción, Iquique
- Age
- 18 years to 75 years
- People
- 30 worldwide
- Run by
- Sanofi
See details and how to joinNCT06984627